A Phase I Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intravenous Bolus and Infusion HRS-9190 in Healthy Adults

NCT07142850 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

49

Enrollment

INDUSTRY

Sponsor class

Conditions

Skeletal Muscle Relaxation

Interventions

DRUG: HRS-9190

Sponsor

Jiangsu HengRui Medicine Co., Ltd.